Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MED4 antisense RNA 1 (MED4-AS1) is a long non-coding RNA (lncRNA) gene transcribed from the opposite strand of the MED4 gene locus on human chromosome 13[1][3][8]. Like other natural antisense transcripts, MED4-AS1 does not code for a protein but is thought to function in the regulation of gene expression, potentially by forming RNA duplexes with sense transcripts (such as MED4 mRNA) and influencing their stability, processing, or translation[1][4]. There are currently no established direct links between MED4-AS1 and specific diseases, no evidence that it functions as a canonical therapeutic target (such as a receptor, enzyme, or transporter), and no reports of drugs that interact with MED4-AS1. Its main molecular classification is as a long non-coding antisense RNA, and its presumed biological role is the regulation of gene expression at the RNA level.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MED4 antisense RNA 1 (MED4-AS1).